Ropes & Gray, the global law firm, represented TPG Growth and Michael Xin Hui in their effort to take private ShangPharma, a China-based contract research organization. Hui is ShangPharma’s CEO. The deal closed on Wednesday.
PRESS RELEASE:
Ropes & Gray represented the buyer group consortium of TPG Growth and ShangPharma’s CEO, Michael Xin Hui, ShangPharma’s going private transaction, which closed March 27.
